BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9605425)

  • 1. Inhibition of the cyclic AMP signaling cascade and nuclear factor binding to CRE and kappaB elements by cannabinol, a minimally CNS-active cannabinoid.
    Herring AC; Koh WS; Kaminski NE
    Biochem Pharmacol; 1998 Apr; 55(7):1013-23. PubMed ID: 9605425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinol-mediated inhibition of nuclear factor-kappaB, cAMP response element-binding protein, and interleukin-2 secretion by activated thymocytes.
    Herring AC; Kaminski NE
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1156-63. PubMed ID: 10565837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of CREB and NF-kappaB signal transduction by cannabinol in activated thymocytes.
    Herring AC; Faubert Kaplan BL; Kaminski NE
    Cell Signal; 2001 Apr; 13(4):241-50. PubMed ID: 11306241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism.
    Kaminski NE; Koh WS; Yang KH; Lee M; Kessler FK
    Biochem Pharmacol; 1994 Nov; 48(10):1899-908. PubMed ID: 7986201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid inhibition of adenylate cyclase-mediated signal transduction and interleukin 2 (IL-2) expression in the murine T-cell line, EL4.IL-2.
    Condie R; Herring A; Koh WS; Lee M; Kaminski NE
    J Biol Chem; 1996 May; 271(22):13175-83. PubMed ID: 8662742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of protein kinase A and cyclic AMP response element (CRE)-specific transcription factor binding by delta9-tetrahydrocannabinol (delta9-THC): a putative mechanism of cannabinoid-induced immune modulation.
    Koh WS; Crawford RB; Kaminski NE
    Biochem Pharmacol; 1997 May; 53(10):1477-84. PubMed ID: 9260875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinol enhancement of interleukin-2 (IL-2) expression by T cells is associated with an increase in IL-2 distal nuclear factor of activated T cell activity.
    Jan TR; Rao GK; Kaminski NE
    Mol Pharmacol; 2002 Feb; 61(2):446-54. PubMed ID: 11809870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor- kappa B/Rel activation.
    Jeon YJ; Yang KH; Pulaski JT; Kaminski NE
    Mol Pharmacol; 1996 Aug; 50(2):334-41. PubMed ID: 8700141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient CRE- and kappa B site-binding is cross-regulated by cAMP-dependent protein kinase and a protein phosphatase in mouse splenocytes.
    Koh WS; Jeon YJ; Herring AC; Kaminski NE
    Life Sci; 1997; 60(6):425-32. PubMed ID: 9031689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes.
    Lee M; Yang KH; Kaminski NE
    J Pharmacol Exp Ther; 1995 Nov; 275(2):529-36. PubMed ID: 7473135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells.
    Ouyang Y; Hwang SG; Han SH; Kaminski NE
    Mol Pharmacol; 1998 Apr; 53(4):676-83. PubMed ID: 9547358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.
    Schatz AR; Lee M; Condie RB; Pulaski JT; Kaminski NE
    Toxicol Appl Pharmacol; 1997 Feb; 142(2):278-87. PubMed ID: 9070350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the cAMP signaling cascade via cannabinoid receptors: a putative mechanism of immune modulation by cannabinoid compounds.
    Kaminski NE
    Toxicol Lett; 1998 Dec; 102-103():59-63. PubMed ID: 10022233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic AMP is an essential factor in immune responses.
    Koh WS; Yang KH; Kaminski NE
    Biochem Biophys Res Commun; 1995 Jan; 206(2):703-9. PubMed ID: 7826390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of leukocyte function and interleukin-2 gene expression by 2-methylarachidonyl-(2'-fluoroethyl)amide, a stable congener of the endogenous cannabinoid receptor ligand anandamide.
    Kaplan BL; Ouyang Y; Herring A; Yea SS; Razdan R; Kaminski NE
    Toxicol Appl Pharmacol; 2005 Jun; 205(2):107-15. PubMed ID: 15893538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AP-1 activity is negatively regulated by cannabinol through inhibition of its protein components, c-fos and c-jun.
    Faubert BL; Kaminski NE
    J Leukoc Biol; 2000 Feb; 67(2):259-66. PubMed ID: 10670588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3.
    Delgado M; Ganea D
    J Immunol; 2001 Jan; 166(2):1028-40. PubMed ID: 11145682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological exposure to melatonin supersensitizes the cyclic adenosine 3',5'-monophosphate-dependent signal transduction cascade in Chinese hamster ovary cells expressing the human mt1 melatonin receptor.
    Witt-Enderby PA; Masana MI; Dubocovich ML
    Endocrinology; 1998 Jul; 139(7):3064-71. PubMed ID: 9645677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PKA and cAMP stimulate proliferation of mouse embryonic stem cells by elevating GLUT1 expression mediated by the NF-κB and CREB/CBP signaling pathways.
    Kim MO; Lee YJ; Park JH; Ryu JM; Yun SP; Han HJ
    Biochim Biophys Acta; 2012 Oct; 1820(10):1636-46. PubMed ID: 22658979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Acetylaminofluorene suppresses immune response through the inhibition of nuclear factor-kappaB activation during the early stage of B cell development.
    Lee M; Yang KH
    Toxicol Lett; 2000 Apr; 114(1-3):173-80. PubMed ID: 10713482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.